Inozyme Pharma Stock Forecast

GVH's stock price has decreased by -96.22% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 1 analyst with a 12-month price forecast for Inozyme Pharma stock has a target of 80, which predicts a 1,456.42% increase from the current stock price of 5.14.

Price Target: $80.00 (+1,456.42%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$80	$80	$80	$80
Change	+1456.4%	+1456.4%	+1456.4%	+1456.4%

Analyst Ratings

According to 1 stock analyst, the rating for Inozyme Pharma is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jul '25
Strong Buy	1
Buy	0
Hold	0
Sell	0
Strong Sell	0
Total	1

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Theodore O'Neill Litchfield Hills	Litchfield Hills	Strong Buy Initiates $80	Strong Buy	Initiates	$80	+1,456.42%	Jul 10, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

n/a

EPS This Year

n/a

EPS Next Year

n/a

No financial forecasts available for this stock

Revenue Forecast

No data available

Revenue Growth

No data available

EPS Forecast

No data available

EPS Growth

No data available

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.